Here are some reimbursement related reasons why access to biosimilars has been slower than hoped, even though patient out-of-pocket costs are lower. Current System Is an Improvement Over Earlier System, But Could Be Better Part B Is For Biologics (and Some Drugs) When I was working at the Senate Legislative Counsel’s office drafting the Average [...] Read More
On Thursday, November 30, 2017, CMS a final rule that cancels the Episode Payment Models (EPMs) and Cardiac Rehabilitation (CR) Incentive Payment Model. The rule also makes participation in the Comprehensive Care for Joint Replacement (CJR) model optional for hospitals located in some areas of the country. The initial proposed rule was released in August […]
Read MoreThis afternoon, CMS released the final rule updating payments for Home Health Agencies (HHAs) for 2017. The rule estimates that payments to HHAs in 2017 will be reduced by 0.7 percent, or roughly $130 million. CMS sees this rule as part of their broader efforts to provide payment based on value, rather than merely quantity […]
Read MoreOn October 5, 2016, the National Institute for Healthcare Management (NIHCM) Foundation hosted a Capitol Hill briefing entitled “The Future of Healthcare in America.” NIHCM brought together a distinguished panel of healthcare thought leaders to discuss what they viewed to be the most important healthcare issues for the next Administration and Congress, as well as […]
Read More